What's new on the horizon for polycystic ovarian syndrome? Exploring emerging drugs in phase II.

D'Angelo, Giuseppe; Ascione, Mario; Morra, Ilaria; Verrazzo, Paolo; Bifulco, Giuseppe; Giampaolino, Pierluigi; Della Corte, Luigi

What's new on the horizon for polycystic ovarian syndrome? Exploring emerging drugs in phase II.

D'Angelo, Giuseppe;Ascione, Mario;Morra, Ilaria;Verrazzo, Paolo;Bifulco, Giuseppe;Giampaolino, Pierluigi;Della Corte, Luigi;

Expert opinion on emerging drugs 2023 pp. 1-4

42

dangelo2023whatsexpert

Keywords

pcos gnrh antagonists neurokinin b receptor antagonism sglt1/2 emerging drugs

Access

DOI:

10.1080/14728214.2023.2260746

Citation

ID: 277043

Ref Key: dangelo2023whatsexpert

Use this key to autocite in SciMatic or Thesis Manager

References

No Bibliography

Blockchain Verification

Account:

NFT Contract Address:

0x95644003c57E6F55A65596E3D9Eac6813e3566dA

Article ID:

277043

Unique Identifier:

10.1080/14728214.2023.2260746

Network:

Scimatic Chain (ID: 481)

Blockchain Readiness Checklist

Authors

Abstract

Journal Name

Year

Title

4/5

Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins

Buy SCI

Saymatik Web3.0 Wallet

Google Play

App Store

What's new on the horizon for polycystic ovarian syndrome? Exploring emerging drugs in phase II.

Keywords

Access

Citation

References

References

Blockchain Verification

Blockchain Readiness Checklist

Saymatik Web3.0 Wallet

About

Services

Legal

License